Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

Cited In for PubMed (Select 14970104)

1.

Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy brazilian population.

Shaharyar S, Roberson LL, Jamal O, Younus A, Blaha MJ, Ali SS, Zide K, Agatston AA, Blumenthal RS, Conceição RD, Santos RD, Nasir K.

J Obes. 2015;2015:178526. doi: 10.1155/2015/178526. Epub 2015 Mar 9.

2.

Association between Metabolic Syndrome, Smoking Status and Coronary Artery Calcification.

Lee YA, Kang SG, Song SW, Rho JS, Kim EK.

PLoS One. 2015 Mar 27;10(3):e0122430. doi: 10.1371/journal.pone.0122430. eCollection 2015.

3.

Food intake does not differ between obese women who are metabolically healthy or abnormal.

Kimokoti RW, Judd SE, Shikany JM, Newby PK.

J Nutr. 2014 Dec;144(12):2018-26. doi: 10.3945/jn.114.198341. Epub 2014 Oct 8.

PMID:
25411036
4.

Association of metabolic syndrome with severity of coronary artery disease.

Mahalle N, Garg MK, Naik SS, Kulkarni MV.

Indian J Endocrinol Metab. 2014 Sep;18(5):708-14. doi: 10.4103/2230-8210.139238.

5.

Nontraditional risk factors for cardiovascular disease and visceral adiposity index among different body size phenotypes.

Du T, Zhang J, Yuan G, Zhang M, Zhou X, Liu Z, Sun X, Yu X.

Nutr Metab Cardiovasc Dis. 2015 Jan;25(1):100-7. doi: 10.1016/j.numecd.2014.07.006. Epub 2014 Aug 7.

PMID:
25159728
6.

Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus.

Mogre V, Salifu ZS, Abedandi R.

J Diabetes Metab Disord. 2014 Jul 15;13:80. doi: 10.1186/2251-6581-13-80. eCollection 2014.

7.

Cardiovascular risk factors have larger impact on endothelial function in self-reported healthy women than men in the HUNT3 Fitness study.

Skaug EA, Madssen E, Aspenes ST, Wisløff U, Ellingsen Ø.

PLoS One. 2014 Jul 3;9(7):e101371. doi: 10.1371/journal.pone.0101371. eCollection 2014.

8.

Progression from metabolically benign to at-risk obesity in perimenopausal women: a longitudinal analysis of study of women across the nation (SWAN).

Khan UI, Wang D, Karvonen-Gutierrez CA, Khalil N, Ylitalo KR, Santoro N.

J Clin Endocrinol Metab. 2014 Jul;99(7):2516-25. doi: 10.1210/jc.2013-3259. Epub 2014 May 20.

PMID:
24846534
9.

The prevalence of metabolic syndrome according to the Iranian Committee of Obesity and ATP III criteria in Babol, North of Iran.

Mahjoub S, Haji Ahmadi M, Faramarzi M, Ghorbani H, Moazezi Z.

Caspian J Intern Med. 2012 Spring;3(2):410-6.

10.

Fitness, fatness, and survival in adults with prediabetes.

McAuley PA, Artero EG, Sui X, Lavie CJ, Almeida MJ, Blair SN.

Diabetes Care. 2014 Feb;37(2):529-36. doi: 10.2337/dc13-1347. Epub 2013 Sep 23.

11.
12.

The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity.

Guo F, Moellering DR, Garvey WT.

Obesity (Silver Spring). 2014 Jan;22(1):110-8. doi: 10.1002/oby.20585. Epub 2013 Sep 5.

13.

Which one is more important, obesity or cardio metabolic risk factors?

Hosseinpanah F.

Int J Endocrinol Metab. 2013 Winter;11(1):1-2. doi: 10.5812/ijem.7963. Epub 2012 Dec 21. No abstract available.

14.

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE, Davidson MH.

Endocr Pract. 2013 May-Jun;19(3):536-57. doi: 10.4158/EP13176.CS. No abstract available.

15.

Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management.

Garvey WT.

Expert Opin Drug Saf. 2013 Sep;12(5):741-56. doi: 10.1517/14740338.2013.806481. Epub 2013 Jun 6. Review.

16.

Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study.

Ogorodnikova AD, Khan UI, McGinn AP, Zeb I, Budoff MJ, Harman SM, Miller VM, Brinton EA, Manson JE, Hodis HN, Merriam GR, Cedars MI, Taylor HS, Naftolin F, Lobo RA, Santoro N, Wildman RP.

Obesity (Silver Spring). 2013 Aug;21(8):1726-33. doi: 10.1002/oby.20200. Epub 2013 May 13.

17.

Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis).

Shah RV, Abbasi SA, Heydari B, Rickers C, Jacobs DR Jr, Wang L, Kwong RY, Bluemke DA, Lima JA, Jerosch-Herold M.

J Am Coll Cardiol. 2013 Apr 23;61(16):1698-706. doi: 10.1016/j.jacc.2013.01.053.

18.

All-cause mortality risk of metabolically healthy obese individuals in NHANES III.

Durward CM, Hartman TJ, Nickols-Richardson SM.

J Obes. 2012;2012:460321. doi: 10.1155/2012/460321. Epub 2012 Dec 5.

19.

The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration.

Hutcheson R, Rocic P.

Exp Diabetes Res. 2012;2012:271028. doi: 10.1155/2012/271028. Epub 2012 Jul 9. Review.

20.

Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing.

Hamer M, Batty GD, Kivimaki M.

Mol Psychiatry. 2012 Sep;17(9):940-5. doi: 10.1038/mp.2012.30. Epub 2012 Apr 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk